Evidence map›Paper›PMID 18008245›Full record

ArticleThe Journal of infectious diseases2007

Spatially and genetically distinct African Trypanosome virulence variants defined by host interferon-gamma response.

Lorna Maclean, Martin Odiit, Annette Macleod, Liam Morrison, Lindsay Sweeney, Anneli Cooper, Peter G E Kennedy, Jeremy M Sternberg

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Plasma cytokines quantification amongMalawi medical journal : the journal of Medical Association of Malawi · 2021
    Article
  5. Article
  6. Veterinary parasitology: X · 2019
    Article
  7. Article
  8. Review
  9. Plasma cytokine profiles associated withAllergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2019
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Kynurenine Pathway Activation in Human African Trypanosomiasis.The Journal of infectious diseases · 2017
    Article
  16. Article
  17. An Overview ofFrontiers in microbiology · 2016
    Review
  18. The role of cytokines in the pathogenesis and staging of Trypanosoma brucei rhodesiense sleeping sickness.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Lorna MacleanSchool of Biological Sciences, University of Aberdeen, Aberdeen, AB24 2TZ, Scotland.
Martin Odiit
Annette Macleod
Liam Morrison
Lindsay Sweeney
Anneli Cooper
Peter G E Kennedy
Jeremy M Sternberg
Wellcome Centre for Molecular Parasitology · GBUniversity of Aberdeen · GBUniversity of Glasgow · GB

Funding

Wellcome Trust 066819Wellcome Trust 074732Wellcome Trust 079703
6 · The paper itself

Abstract

We describe 2 spatially distinct foci of human African trypanosomiasis in eastern Uganda. The Tororo and Soroti foci of Trypanosoma brucei rhodesiense infection were genetically distinct as characterized by 6 microsatellite and 1 minisatellite polymorphic markers and were characterized by differences in disease progression and host-immune response. In particular, infections with the Tororo genotype exhibited an increased frequency of progression to and severity of the meningoencephalitic stage and higher plasma interferon (IFN)- gamma concentration, compared with those with the Soroti genotype. We propose that the magnitude of the systemic IFN- gamma response determines the time at which infected individuals develop central nervous system infection and that this is consistent with the recently described role of IFN- gamma in facilitating blood-brain barrier transmigration of trypanosomes in an experimental model of infection. The identification of trypanosome isolates with differing disease progression phenotypes provides the first field-based genetic evidence for virulence variants in T. brucei rhodesiense.

Indexed as

AnimalsAntiviral AgentsBlood-Brain BarrierComaDisease ProgressionGenotypeGlasgow Coma ScaleHost-Parasite InteractionsHumansInterferon-gammaInterleukinsMalaria, CerebralPhenotypePolymerase Chain ReactionSeverity of Illness IndexTrypanosoma brucei rhodesienseAntiviral AgentsInterferon-gammaInterleukins

Identifiers

PMID18008245
PMCPMC2082664
OpenAlexW2154388629

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.